{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:25:51Z","timestamp":1788830751297,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jemermed.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T09:19:10Z","timestamp":1571390350000},"page":"689-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oncologic Emergencies: The Fever With Too Few Neutrophils"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2019.08.009_bib1","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jemermed.2019.08.009_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.emc.2018.04.001","article-title":"Rapid fire: infectious disease emergencies in patients with cancer","volume":"36","author":"Charshafian","year":"2018","journal-title":"Emerg Med Clin N Am"},{"key":"10.1016\/j.jemermed.2019.08.009_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.emc.2018.06.009","article-title":"Infectious disease emergencies in oncology patients","volume":"36","author":"Cantwell","year":"2018","journal-title":"Emerg Med Clin N Am"},{"key":"10.1016\/j.jemermed.2019.08.009_bib4","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3111\/13696998.2013.782034","article-title":"A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia","volume":"16","author":"Dulisse","year":"2013","journal-title":"J Med Econ"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2019.08.009_bib6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.leukres.2015.01.006","article-title":"Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up","volume":"39","author":"Bryant","year":"2015","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.jemermed.2019.08.009_bib8","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jemermed.2019.08.009_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cncr.25691","article-title":"Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy","volume":"117","author":"Lyman","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1200\/JOP.091092","article-title":"How we treat febrile neutropenia in patients receiving cancer chemotherapy","volume":"6","author":"Lyman","year":"2010","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jemermed.2019.08.009_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1553-2712.2009.00649.x","article-title":"Risk of serious bacterial infection in isolated and unsuspected neutropenia","volume":"17","author":"Melendez","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib14","first-page":"2371","article-title":"Korean Network for Study on Infectious Diseases (KONSID). Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia","volume":"20","author":"Kang","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-004-3049-5","article-title":"Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome","volume":"32","author":"Anatoliotaki","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.jemermed.2019.08.009_bib16","first-page":"135","article-title":"Infections in haematologic neoplasms: autopsy findings","volume":"76","author":"Nosari","year":"1991","journal-title":"Haematologica"},{"key":"10.1016\/j.jemermed.2019.08.009_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/598620","article-title":"Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria","volume":"29","author":"Zinner","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2019.08.009_bib19","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","article-title":"Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens","volume":"39","author":"Ramphal","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1705677","article-title":"Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients","volume":"39","author":"Oliveira","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jemermed.2019.08.009_bib21","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2008.21.0856","article-title":"Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve","volume":"27","author":"Portugal","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib22","first-page":"698","article-title":"Current spectrum of bacterial infections in patients with nosocomial fever and neutropenia","volume":"4","author":"Yadegarynia","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12288-014-0393-1","article-title":"Micro-organisms associated with febrile neutropenia in patients with haematological malignancies in a tertiary care hospital in eastern India","volume":"31","author":"Mandal","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2019.08.009_bib24","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1086\/383042","article-title":"Microbiological data for patients with febrile neutropenia","volume":"39","author":"Kanamaru","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"10.1016\/j.jemermed.2019.08.009_bib25","doi-asserted-by":"crossref","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","article-title":"Management of febrile neutropenia: ESMO Clinical Practice Guidelines","volume":"21","author":"de Naurois","year":"2010","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2019.08.009_bib26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/0924-8579(93)90041-3","article-title":"Respiratory infections in the immunocompromised patient","volume":"3","author":"Aoun","year":"1993","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jemermed.2019.08.009_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00330-003-1985-6","article-title":"Pneumonia in neutropenic patients","volume":"14","author":"Heussel","year":"2004","journal-title":"Eur Radiol"},{"issue":"suppl 5","key":"10.1016\/j.jemermed.2019.08.009_bib28","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1093\/cid\/ciu623","article-title":"Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies","volume":"59","author":"Chemaly","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0733-8619(02)00075-0","article-title":"Nervous system infections in patients with cancer","volume":"21","author":"Pruitt","year":"2003","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jemermed.2019.08.009_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/CMR.4.2.169","article-title":"Epidemiology of human listeriosis","volume":"4","author":"Schuchat","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jemermed.2019.08.009_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s15010-015-0830-6","article-title":"Biomarker candidates for the detection of an infectious etiology of febrile neutropenia","volume":"44","author":"Richter","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.jemermed.2019.08.009_bib32","doi-asserted-by":"crossref","first-page":"9805609","DOI":"10.1155\/2017\/9805609","article-title":"Soluble CD14 as a diagnostic and prognostic biomarker in hematological patients with febrile neutropenia","volume":"2017","author":"Korpelainen","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.jemermed.2019.08.009_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365548.2014.985711","article-title":"Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients","volume":"47","author":"Purhonen","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jemermed.2019.08.009_bib34","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4081\/hr.2014.5466","article-title":"Intensive serial biomarker profiling for the prediction of neutropenic fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study","volume":"6","author":"Chan","year":"2014","journal-title":"Hematol Rep"},{"key":"10.1016\/j.jemermed.2019.08.009_bib35","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1016\/j.ijid.2013.04.004","article-title":"The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies","volume":"17","author":"Kaya","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hemonc.2016.09.002","article-title":"Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens","volume":"10","author":"Stoma","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jemermed.2019.08.009_bib37","first-page":"539","article-title":"Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than c-reactive protein","volume":"23","author":"von Lilienfeld-Toal","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib38","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s15010-008-7374-y","article-title":"The role of procalcitonin in febrile neutropenic patients: review of the literature","volume":"36","author":"Sakr","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jemermed.2019.08.009_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/17474086.2017.1326813","article-title":"Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients","volume":"10","author":"Bruno","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib40","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","article-title":"The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis","volume":"21","author":"Hoeboer","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jemermed.2019.08.009_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22147","article-title":"Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies","volume":"31","author":"Ebihara","year":"2017","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jemermed.2019.08.009_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib43","first-page":"CD003038","article-title":"Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia","volume":"6","author":"Paul","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jemermed.2019.08.009_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.idc.2010.11.012","article-title":"Central line-associated bloodstream infections: prevention and management","volume":"25","author":"Weber","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jemermed.2019.08.009_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.idc.2007.03.003","article-title":"Mucositis in the cancer patient and immunosuppressed host","volume":"21","author":"Epstein","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jemermed.2019.08.009_bib47","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajem.2015.08.037","article-title":"Mucormycosis: what emergency physicians need to know?","volume":"33","author":"Long","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib48","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.ajem.2018.06.074","article-title":"Infectious endocarditis: an update for emergency clinicians","volume":"36","author":"Long","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jemermed.2016.02.009","article-title":"Top ten myths regarding the diagnosis and treatment of urinary tract infections","volume":"51","author":"Schulz","year":"2016","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib50","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cis998","article-title":"Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy","volume":"56","author":"Nesher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2012.5815","article-title":"Typhlitis: a neutropenic complication","volume":"2012","author":"Shahani","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jemermed.2019.08.009_bib52","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/CCM.0000000000003687","article-title":"Neutropenic enterocolitis in critically ill patients: spectrum of the disease and risk of invasive fungal disease","volume":"47","author":"Duceau","year":"2019","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jemermed.2019.08.009_bib53","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2019.08.009_bib54","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cgh.2013.03.016","article-title":"Diagnosis and management of Clostridium difficile infection","volume":"11","author":"Dupont","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib55","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/01.wnl.0000305960.85546.5f","article-title":"Bacterial and fungal meningitis in patients with cancer","volume":"70","author":"Safdieh","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2019.08.009_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.34.3.269","article-title":"Bacterial infections of the CNS in neutropenic patients","volume":"34","author":"Lukes","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2019.08.009_bib57","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib58","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib59","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinte.1975.00330050089015","article-title":"Clinical presentation of infection in granulocytopenic patients","volume":"135","author":"Sickles","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib60","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib61","first-page":"1487","article-title":"The multinational association for supportive care in cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients","volume":"21","author":"Klastersky","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib62","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","article-title":"Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications","volume":"24","author":"Klastersky","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib63","first-page":"485","article-title":"Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice","volume":"16","author":"Innes","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/14-188","article-title":"Utility of the Multinational Association for Supportive Care in Cancer (MASCC) risk index score as a criterion for nonadmission in febrile neutropenic patients with solid tumors","volume":"19","author":"Bitar","year":"2015","journal-title":"Perm J"},{"key":"10.1016\/j.jemermed.2019.08.009_bib65","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"Carmona-Bayonas","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jemermed.2019.08.009_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","article-title":"Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study","volume":"33","author":"Carmona-Bayonas","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2019.08.009_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.annemergmed.2016.11.007","article-title":"Application of the MASCC and CISNE risk stratification scores to identify low-risk febrile neutropenic patients in the emergency department","volume":"69","author":"Coyne","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2019.08.009_bib68","first-page":"215","article-title":"The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies","volume":"91","author":"Cherif","year":"2006","journal-title":"Haematologica"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919306614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467919306614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:44:28Z","timestamp":1760028268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467919306614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0736467919306614"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.08.009","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic Emergencies: The Fever With Too Few Neutrophils","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}